loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Pharmaceutical Excipients offered by Microlex e.U? Find Talc API to address your drug delivery challenges on PharmaCompass.

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    View Presentation

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Menu

    Talc API

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 251,591Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 11Microlex e.U

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    Microlex e.U

    MICROLEX® SA-121

    arrow
    Peptide Therapy Summit
    Not Confirmed

    Microlex e.U

    Austria
    arrow
    Peptide Therapy Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Topical, Oral

    Brand Name : Microlex® SA-121

    Application : Fillers, Diluents & Binders, Lubricants & Glidants

    Excipient Details : It is available in the range of carefully engineered Stearic Acids. Very fine quality of a vegetable Stearic Acid designed for tableting and flowability agent in specific pharmaceutical formulation.

    Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, JP/...

    Technical Specs :

    Ingredient(s) : Stearic Acid

    Dosage Form : Tablet

    Grade : Topical, Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Stearic Acid

    Dosage Form : Tablet

    Category : Fillers, Diluents & Binders, Lubricants & Glidants

    Brand : MICROLEX® SA-121

    Applications : It is available in the range of carefully engineered Stearic Acids. Very fine quality of a vegetable Stearic Acid designed for tableting and flowability agent in specific pharmaceutical formulation.

    Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, JP/JPE

    Technical Specs : Not Available

    Grade : Topical, Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    02

    Microlex e.U

    MICROLEX® SA-122

    arrow
    Peptide Therapy Summit
    Not Confirmed

    03

    Microlex e.U

    MICROLEX® CS-141

    arrow
    Peptide Therapy Summit
    Not Confirmed

    04

    Microlex e.U

    MICROLEX® CS-142

    arrow
    Peptide Therapy Summit
    Not Confirmed

    05

    Microlex e.U

    MICROLEX® CMC M

    arrow
    Peptide Therapy Summit
    Not Confirmed

    06

    Microlex e.U

    MICROLEX® CMC L

    arrow
    Peptide Therapy Summit
    Not Confirmed

    07

    Microlex e.U

    MICROLEX® CMC H

    arrow
    Peptide Therapy Summit
    Not Confirmed

    08

    Microlex e.U

    MICROLEX® MCC 101

    arrow
    Peptide Therapy Summit
    Not Confirmed

    09

    Microlex e.U

    MICROLEX® MCC 102

    arrow
    Peptide Therapy Summit
    Not Confirmed

    Microlex e.U

    Austria
    arrow
    Peptide Therapy Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral

    Brand Name : Microlex® MCC 102

    Application : Direct Compression

    Excipient Details : The plastic defamation characteristics of  MCC 102 type mean that very hard tablets can be produced at light compaction forces, extending tooling lifetime and solving problems with poorly compressible actives.

    Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

    Technical Specs :

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Tablet

    Category : Direct Compression

    Brand : MICROLEX® MCC 102

    Applications : The plastic defamation characteristics of  MCC 102 type mean that very hard tablets can be produced at light compaction forces, extending tooling lifetime and solving problems with poorly compressible actives.

    Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE

    Technical Specs : Not Available

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    10

    Microlex e.U

    MICROLEX® MGS-INJ 500

    arrow
    Peptide Therapy Summit
    Not Confirmed